Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 32

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 32
---
 and become                                                                                                          
 exercisable in 36 consecutive monthly installments, beginning April 30, 2022 and continuing through March 31, 2025.              |

Stock Option Grants

The following table summarizes stock option grants during fiscal year 2024.

| 19 |

| GRANTS OF OPTION AWARDS 
 Name                    |     | Grant Date |     | Number of   
 Securities  
 Underlying  
 Unexercised 
 Options (#) |         |     | Exercise Price 
 of Option      
 Awards ($)     |      |     | Grant Date        
 Fair Value ($)(1) |           |
|:------------------------|:----|:-----------|:----|:------------|--------:|:----|:---------------|-----:|:----|:------------------|----------:|
| Dr. Amit Kumar          |     | 1/12/2024  |     |             | 700,000 |     | $              | 4.39 |     | $                 | 2,093,000 |
| Michael J. Catelani     |     | 1/12/2024  |     |             | 350,000 |     | $              | 4.39 |     | $                 | 1,046,500 |

| (1) | These amounts have been                                                                                                              
 calculated in accordance with ASC 718. A discussion of assumptions used in valuation of option awards may be found in Note 2 to our  
 Consolidated Financial Statements for fiscal year ended October 31, 2024, included in our Annual Report on Form 10-K. These amounts  
 reflect our accounting expense for these stock options and do not correspond to the actual value that may be recognized by our Named 
 Executive Officers.                                                                                                                  |

Stock Option Exercises

During the year ended October 31, 2024, neither Dr. Kumar nor Mr. Catelani exercised any stock options.

Stock Awards

There are currently no outstanding restricted stock awards.

Timing of Equity Awards

The Board and Compensation Committee grant awards without regard to the share price or the timing of the release of material nonpublic information and do not time grants for the purpose of affecting the value of executive compensation. Accordingly, it is our policy that our management team makes a good faith effort to advise the Board and Compensation Committee whenever it is aware that material nonpublic information is planned to be released to the public in close proximity to the grant of equity awards.

Potential Payments upon Termination or Change in Control

Dr. Amit